Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bain

Showing results (261-270 of 494) with videos related to

Pageof 50
Sort By:
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2018
A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist interventionB C T Field, R Nayar, A Kilvert, et al.
Medicine and Science in Sports and Exercise|December 14, 2020
Blood Glucose Responses during Cardiopulmonary Incremental Exercise Testing in Type 1 Diabetes: A Pooled AnalysisOlivia McCarthy, Jason Pitt, Ben Wellman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 25, 2000
Comparison of testing saliva and serum for detection of antibody to human immunodeficiency virus in Jamaica, West IndiesS D King, S H Wynter, B C Bain, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2012
IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycinRobert J Salmond, Ananda S Mirchandani, Anne-Gaelle Besnard, et al.
Blood|December 9, 1998
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factorC Menetrier-Caux, G Montmain, M C Dieu, et al.
The Lancet. Diabetes & Endocrinology|January 24, 2017
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trialChristopher Sorli, Shin-Ichi Harashima, George M Tsoukas, et al.
Kidney International Reports|July 31, 2024
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 TrialKatherine R Tuttle, Stephen C Bain, Heidrun Bosch-Traberg, et al.
JAMA Cardiology|November 14, 2019
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical TrialSubodh Verma, Stephen C Bain, John B Buse, et al.
Diabetologia|July 1, 1997
A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the youngM P Bulman, M J Dronsfield, T Frayling, et al.
Pageof 50

Showing results (261-270 of 494) with videos related to

Sort By:
Pageof 50
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2018
A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist interventionB C T Field, R Nayar, A Kilvert, et al.
Medicine and Science in Sports and Exercise|December 14, 2020
Blood Glucose Responses during Cardiopulmonary Incremental Exercise Testing in Type 1 Diabetes: A Pooled AnalysisOlivia McCarthy, Jason Pitt, Ben Wellman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 25, 2000
Comparison of testing saliva and serum for detection of antibody to human immunodeficiency virus in Jamaica, West IndiesS D King, S H Wynter, B C Bain, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2012
IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycinRobert J Salmond, Ananda S Mirchandani, Anne-Gaelle Besnard, et al.
Blood|December 9, 1998
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factorC Menetrier-Caux, G Montmain, M C Dieu, et al.
The Lancet. Diabetes & Endocrinology|January 24, 2017
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trialChristopher Sorli, Shin-Ichi Harashima, George M Tsoukas, et al.
Kidney International Reports|July 31, 2024
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 TrialKatherine R Tuttle, Stephen C Bain, Heidrun Bosch-Traberg, et al.
JAMA Cardiology|November 14, 2019
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical TrialSubodh Verma, Stephen C Bain, John B Buse, et al.
Diabetologia|July 1, 1997
A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the youngM P Bulman, M J Dronsfield, T Frayling, et al.
Pageof 50